Skip to main content
. 2023 Nov 16;42(4):431–440. doi: 10.1200/JCO.23.00954

FIG 4.

FIG 4.

PFS by HPV DNA copy number in plasma on HPV-seq at (A) end of CRT, (B) 4-6 weeks post-CRT, and (C) 3 months post-CRT. CRT, chemoradiation; ctDNA, circulating tumor DNA; HPV, human papilloma virus; HR, hazard ratio; PFS, progression-free survival.